Calamos Advisors
SGFY

Calamos Advisors’s Signify Health, Inc. SGFY Stock Holding History

Calamos Advisors’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-442,574
Closed -$12.7M – 1264
2022
Q4 		$12.7M Buy
+442,574
New +$12.8M 0.06% 392

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Calamos Advisors's SGFY Position: Q1 2023 in Review

Calamos Advisors sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 442,574 shares — an estimated $12.7M sold.

Calamos Advisors first reported a position in SGFY in Q4 2022 and held it in 1 quarter. The position peaked at $12.7M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Calamos Advisors reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Calamos Advisors sold 442,574 Signify Health, Inc. shares in Q1 2023, an estimated $12.7M.
  • Calamos Advisors first reported a position in Signify Health, Inc. in Q4 2022 and held it in 1 quarter.
  • Calamos Advisors's Signify Health, Inc. position peaked at $12.7M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Calamos Advisors's 13F filing for Q1 2023, filed 4 May 2023.